Global Fragment-based Drug Discovery Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Fragment-based Drug Discovery market size was valued at US$ 325.6 million in 2023. With growing demand in downstream market, the Fragment-based Drug Discovery is forecast to a readjusted size of US$ 514.1 million by 2030 with a CAGR of 6.7% during review period.
The research report highlights the growth potential of the global Fragment-based Drug Discovery market. Fragment-based Drug Discovery are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Fragment-based Drug Discovery. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Fragment-based Drug Discovery market.
The introduction of new techniques into the existing fragment-based drug discovery practices have created significant reductions in time and cost, driving the demand for such practices.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Fragment-based Drug Discovery market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Fragment-based Drug Discovery market. It may include historical data, market segmentation by Type (e.g., Fragment Screening, Fragment Optimization), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Fragment-based Drug Discovery market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Fragment-based Drug Discovery market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Fragment-based Drug Discovery industry. This include advancements in Fragment-based Drug Discovery technology, Fragment-based Drug Discovery new entrants, Fragment-based Drug Discovery new investment, and other innovations that are shaping the future of Fragment-based Drug Discovery.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Fragment-based Drug Discovery market. It includes factors influencing customer ' purchasing decisions, preferences for Fragment-based Drug Discovery product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Fragment-based Drug Discovery market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Fragment-based Drug Discovery market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Fragment-based Drug Discovery market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Fragment-based Drug Discovery industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Fragment-based Drug Discovery market.
Market Segmentation:
Fragment-based Drug Discovery market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Fragment-based Drug Discovery market size was valued at US$ 325.6 million in 2023. With growing demand in downstream market, the Fragment-based Drug Discovery is forecast to a readjusted size of US$ 514.1 million by 2030 with a CAGR of 6.7% during review period.
The research report highlights the growth potential of the global Fragment-based Drug Discovery market. Fragment-based Drug Discovery are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Fragment-based Drug Discovery. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Fragment-based Drug Discovery market.
The introduction of new techniques into the existing fragment-based drug discovery practices have created significant reductions in time and cost, driving the demand for such practices.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Fragment-based Drug Discovery market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Fragment-based Drug Discovery market. It may include historical data, market segmentation by Type (e.g., Fragment Screening, Fragment Optimization), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Fragment-based Drug Discovery market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Fragment-based Drug Discovery market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Fragment-based Drug Discovery industry. This include advancements in Fragment-based Drug Discovery technology, Fragment-based Drug Discovery new entrants, Fragment-based Drug Discovery new investment, and other innovations that are shaping the future of Fragment-based Drug Discovery.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Fragment-based Drug Discovery market. It includes factors influencing customer ' purchasing decisions, preferences for Fragment-based Drug Discovery product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Fragment-based Drug Discovery market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Fragment-based Drug Discovery market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Fragment-based Drug Discovery market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Fragment-based Drug Discovery industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Fragment-based Drug Discovery market.
Market Segmentation:
Fragment-based Drug Discovery market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Fragment Screening
- Fragment Optimization
- Academic and Research Institutions
- Biopharmaceutical Companies
- Contract Research Organizations (CROs)
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Astex Pharmaceuticals
- Alveus Pharmaceuticals
- Beactica
- Charles River Laboratories
- Crown Bioscience
- Emerald BioStructures
- Evotec
- Kinetic Discovery
- Proteros Fragments
- Sprint Bioscience
- Structure Based Design
- Sygnature Discovery
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Fragment-based Drug Discovery Market Size 2019-2030
2.1.2 Fragment-based Drug Discovery Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Fragment-based Drug Discovery Segment by Type
2.2.1 Fragment Screening
2.2.2 Fragment Optimization
2.3 Fragment-based Drug Discovery Market Size by Type
2.3.1 Fragment-based Drug Discovery Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Fragment-based Drug Discovery Market Size Market Share by Type (2019-2024)
2.4 Fragment-based Drug Discovery Segment by Application
2.4.1 Academic and Research Institutions
2.4.2 Biopharmaceutical Companies
2.4.3 Contract Research Organizations (CROs)
2.5 Fragment-based Drug Discovery Market Size by Application
2.5.1 Fragment-based Drug Discovery Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Fragment-based Drug Discovery Market Size Market Share by Application (2019-2024)
3 FRAGMENT-BASED DRUG DISCOVERY MARKET SIZE BY PLAYER
3.1 Fragment-based Drug Discovery Market Size Market Share by Players
3.1.1 Global Fragment-based Drug Discovery Revenue by Players (2019-2024)
3.1.2 Global Fragment-based Drug Discovery Revenue Market Share by Players (2019-2024)
3.2 Global Fragment-based Drug Discovery Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 FRAGMENT-BASED DRUG DISCOVERY BY REGIONS
4.1 Fragment-based Drug Discovery Market Size by Regions (2019-2024)
4.2 Americas Fragment-based Drug Discovery Market Size Growth (2019-2024)
4.3 APAC Fragment-based Drug Discovery Market Size Growth (2019-2024)
4.4 Europe Fragment-based Drug Discovery Market Size Growth (2019-2024)
4.5 Middle East & Africa Fragment-based Drug Discovery Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Fragment-based Drug Discovery Market Size by Country (2019-2024)
5.2 Americas Fragment-based Drug Discovery Market Size by Type (2019-2024)
5.3 Americas Fragment-based Drug Discovery Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Fragment-based Drug Discovery Market Size by Region (2019-2024)
6.2 APAC Fragment-based Drug Discovery Market Size by Type (2019-2024)
6.3 APAC Fragment-based Drug Discovery Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Fragment-based Drug Discovery by Country (2019-2024)
7.2 Europe Fragment-based Drug Discovery Market Size by Type (2019-2024)
7.3 Europe Fragment-based Drug Discovery Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Fragment-based Drug Discovery by Region (2019-2024)
8.2 Middle East & Africa Fragment-based Drug Discovery Market Size by Type (2019-2024)
8.3 Middle East & Africa Fragment-based Drug Discovery Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL FRAGMENT-BASED DRUG DISCOVERY MARKET FORECAST
10.1 Global Fragment-based Drug Discovery Forecast by Regions (2025-2030)
10.1.1 Global Fragment-based Drug Discovery Forecast by Regions (2025-2030)
10.1.2 Americas Fragment-based Drug Discovery Forecast
10.1.3 APAC Fragment-based Drug Discovery Forecast
10.1.4 Europe Fragment-based Drug Discovery Forecast
10.1.5 Middle East & Africa Fragment-based Drug Discovery Forecast
10.2 Americas Fragment-based Drug Discovery Forecast by Country (2025-2030)
10.2.1 United States Fragment-based Drug Discovery Market Forecast
10.2.2 Canada Fragment-based Drug Discovery Market Forecast
10.2.3 Mexico Fragment-based Drug Discovery Market Forecast
10.2.4 Brazil Fragment-based Drug Discovery Market Forecast
10.3 APAC Fragment-based Drug Discovery Forecast by Region (2025-2030)
10.3.1 China Fragment-based Drug Discovery Market Forecast
10.3.2 Japan Fragment-based Drug Discovery Market Forecast
10.3.3 Korea Fragment-based Drug Discovery Market Forecast
10.3.4 Southeast Asia Fragment-based Drug Discovery Market Forecast
10.3.5 India Fragment-based Drug Discovery Market Forecast
10.3.6 Australia Fragment-based Drug Discovery Market Forecast
10.4 Europe Fragment-based Drug Discovery Forecast by Country (2025-2030)
10.4.1 Germany Fragment-based Drug Discovery Market Forecast
10.4.2 France Fragment-based Drug Discovery Market Forecast
10.4.3 UK Fragment-based Drug Discovery Market Forecast
10.4.4 Italy Fragment-based Drug Discovery Market Forecast
10.4.5 Russia Fragment-based Drug Discovery Market Forecast
10.5 Middle East & Africa Fragment-based Drug Discovery Forecast by Region (2025-2030)
10.5.1 Egypt Fragment-based Drug Discovery Market Forecast
10.5.2 South Africa Fragment-based Drug Discovery Market Forecast
10.5.3 Israel Fragment-based Drug Discovery Market Forecast
10.5.4 Turkey Fragment-based Drug Discovery Market Forecast
10.5.5 GCC Countries Fragment-based Drug Discovery Market Forecast
10.6 Global Fragment-based Drug Discovery Forecast by Type (2025-2030)
10.7 Global Fragment-based Drug Discovery Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Astex Pharmaceuticals
11.1.1 Astex Pharmaceuticals Company Information
11.1.2 Astex Pharmaceuticals Fragment-based Drug Discovery Product Offered
11.1.3 Astex Pharmaceuticals Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Astex Pharmaceuticals Main Business Overview
11.1.5 Astex Pharmaceuticals Latest Developments
11.2 Alveus Pharmaceuticals
11.2.1 Alveus Pharmaceuticals Company Information
11.2.2 Alveus Pharmaceuticals Fragment-based Drug Discovery Product Offered
11.2.3 Alveus Pharmaceuticals Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Alveus Pharmaceuticals Main Business Overview
11.2.5 Alveus Pharmaceuticals Latest Developments
11.3 Beactica
11.3.1 Beactica Company Information
11.3.2 Beactica Fragment-based Drug Discovery Product Offered
11.3.3 Beactica Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Beactica Main Business Overview
11.3.5 Beactica Latest Developments
11.4 Charles River Laboratories
11.4.1 Charles River Laboratories Company Information
11.4.2 Charles River Laboratories Fragment-based Drug Discovery Product Offered
11.4.3 Charles River Laboratories Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Charles River Laboratories Main Business Overview
11.4.5 Charles River Laboratories Latest Developments
11.5 Crown Bioscience
11.5.1 Crown Bioscience Company Information
11.5.2 Crown Bioscience Fragment-based Drug Discovery Product Offered
11.5.3 Crown Bioscience Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Crown Bioscience Main Business Overview
11.5.5 Crown Bioscience Latest Developments
11.6 Emerald BioStructures
11.6.1 Emerald BioStructures Company Information
11.6.2 Emerald BioStructures Fragment-based Drug Discovery Product Offered
11.6.3 Emerald BioStructures Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Emerald BioStructures Main Business Overview
11.6.5 Emerald BioStructures Latest Developments
11.7 Evotec
11.7.1 Evotec Company Information
11.7.2 Evotec Fragment-based Drug Discovery Product Offered
11.7.3 Evotec Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Evotec Main Business Overview
11.7.5 Evotec Latest Developments
11.8 Kinetic Discovery
11.8.1 Kinetic Discovery Company Information
11.8.2 Kinetic Discovery Fragment-based Drug Discovery Product Offered
11.8.3 Kinetic Discovery Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Kinetic Discovery Main Business Overview
11.8.5 Kinetic Discovery Latest Developments
11.9 Proteros Fragments
11.9.1 Proteros Fragments Company Information
11.9.2 Proteros Fragments Fragment-based Drug Discovery Product Offered
11.9.3 Proteros Fragments Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Proteros Fragments Main Business Overview
11.9.5 Proteros Fragments Latest Developments
11.10 Sprint Bioscience
11.10.1 Sprint Bioscience Company Information
11.10.2 Sprint Bioscience Fragment-based Drug Discovery Product Offered
11.10.3 Sprint Bioscience Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Sprint Bioscience Main Business Overview
11.10.5 Sprint Bioscience Latest Developments
11.11 Structure Based Design
11.11.1 Structure Based Design Company Information
11.11.2 Structure Based Design Fragment-based Drug Discovery Product Offered
11.11.3 Structure Based Design Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Structure Based Design Main Business Overview
11.11.5 Structure Based Design Latest Developments
11.12 Sygnature Discovery
11.12.1 Sygnature Discovery Company Information
11.12.2 Sygnature Discovery Fragment-based Drug Discovery Product Offered
11.12.3 Sygnature Discovery Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Sygnature Discovery Main Business Overview
11.12.5 Sygnature Discovery Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Fragment-based Drug Discovery Market Size 2019-2030
2.1.2 Fragment-based Drug Discovery Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Fragment-based Drug Discovery Segment by Type
2.2.1 Fragment Screening
2.2.2 Fragment Optimization
2.3 Fragment-based Drug Discovery Market Size by Type
2.3.1 Fragment-based Drug Discovery Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Fragment-based Drug Discovery Market Size Market Share by Type (2019-2024)
2.4 Fragment-based Drug Discovery Segment by Application
2.4.1 Academic and Research Institutions
2.4.2 Biopharmaceutical Companies
2.4.3 Contract Research Organizations (CROs)
2.5 Fragment-based Drug Discovery Market Size by Application
2.5.1 Fragment-based Drug Discovery Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Fragment-based Drug Discovery Market Size Market Share by Application (2019-2024)
3 FRAGMENT-BASED DRUG DISCOVERY MARKET SIZE BY PLAYER
3.1 Fragment-based Drug Discovery Market Size Market Share by Players
3.1.1 Global Fragment-based Drug Discovery Revenue by Players (2019-2024)
3.1.2 Global Fragment-based Drug Discovery Revenue Market Share by Players (2019-2024)
3.2 Global Fragment-based Drug Discovery Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 FRAGMENT-BASED DRUG DISCOVERY BY REGIONS
4.1 Fragment-based Drug Discovery Market Size by Regions (2019-2024)
4.2 Americas Fragment-based Drug Discovery Market Size Growth (2019-2024)
4.3 APAC Fragment-based Drug Discovery Market Size Growth (2019-2024)
4.4 Europe Fragment-based Drug Discovery Market Size Growth (2019-2024)
4.5 Middle East & Africa Fragment-based Drug Discovery Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Fragment-based Drug Discovery Market Size by Country (2019-2024)
5.2 Americas Fragment-based Drug Discovery Market Size by Type (2019-2024)
5.3 Americas Fragment-based Drug Discovery Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Fragment-based Drug Discovery Market Size by Region (2019-2024)
6.2 APAC Fragment-based Drug Discovery Market Size by Type (2019-2024)
6.3 APAC Fragment-based Drug Discovery Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Fragment-based Drug Discovery by Country (2019-2024)
7.2 Europe Fragment-based Drug Discovery Market Size by Type (2019-2024)
7.3 Europe Fragment-based Drug Discovery Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Fragment-based Drug Discovery by Region (2019-2024)
8.2 Middle East & Africa Fragment-based Drug Discovery Market Size by Type (2019-2024)
8.3 Middle East & Africa Fragment-based Drug Discovery Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL FRAGMENT-BASED DRUG DISCOVERY MARKET FORECAST
10.1 Global Fragment-based Drug Discovery Forecast by Regions (2025-2030)
10.1.1 Global Fragment-based Drug Discovery Forecast by Regions (2025-2030)
10.1.2 Americas Fragment-based Drug Discovery Forecast
10.1.3 APAC Fragment-based Drug Discovery Forecast
10.1.4 Europe Fragment-based Drug Discovery Forecast
10.1.5 Middle East & Africa Fragment-based Drug Discovery Forecast
10.2 Americas Fragment-based Drug Discovery Forecast by Country (2025-2030)
10.2.1 United States Fragment-based Drug Discovery Market Forecast
10.2.2 Canada Fragment-based Drug Discovery Market Forecast
10.2.3 Mexico Fragment-based Drug Discovery Market Forecast
10.2.4 Brazil Fragment-based Drug Discovery Market Forecast
10.3 APAC Fragment-based Drug Discovery Forecast by Region (2025-2030)
10.3.1 China Fragment-based Drug Discovery Market Forecast
10.3.2 Japan Fragment-based Drug Discovery Market Forecast
10.3.3 Korea Fragment-based Drug Discovery Market Forecast
10.3.4 Southeast Asia Fragment-based Drug Discovery Market Forecast
10.3.5 India Fragment-based Drug Discovery Market Forecast
10.3.6 Australia Fragment-based Drug Discovery Market Forecast
10.4 Europe Fragment-based Drug Discovery Forecast by Country (2025-2030)
10.4.1 Germany Fragment-based Drug Discovery Market Forecast
10.4.2 France Fragment-based Drug Discovery Market Forecast
10.4.3 UK Fragment-based Drug Discovery Market Forecast
10.4.4 Italy Fragment-based Drug Discovery Market Forecast
10.4.5 Russia Fragment-based Drug Discovery Market Forecast
10.5 Middle East & Africa Fragment-based Drug Discovery Forecast by Region (2025-2030)
10.5.1 Egypt Fragment-based Drug Discovery Market Forecast
10.5.2 South Africa Fragment-based Drug Discovery Market Forecast
10.5.3 Israel Fragment-based Drug Discovery Market Forecast
10.5.4 Turkey Fragment-based Drug Discovery Market Forecast
10.5.5 GCC Countries Fragment-based Drug Discovery Market Forecast
10.6 Global Fragment-based Drug Discovery Forecast by Type (2025-2030)
10.7 Global Fragment-based Drug Discovery Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Astex Pharmaceuticals
11.1.1 Astex Pharmaceuticals Company Information
11.1.2 Astex Pharmaceuticals Fragment-based Drug Discovery Product Offered
11.1.3 Astex Pharmaceuticals Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Astex Pharmaceuticals Main Business Overview
11.1.5 Astex Pharmaceuticals Latest Developments
11.2 Alveus Pharmaceuticals
11.2.1 Alveus Pharmaceuticals Company Information
11.2.2 Alveus Pharmaceuticals Fragment-based Drug Discovery Product Offered
11.2.3 Alveus Pharmaceuticals Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Alveus Pharmaceuticals Main Business Overview
11.2.5 Alveus Pharmaceuticals Latest Developments
11.3 Beactica
11.3.1 Beactica Company Information
11.3.2 Beactica Fragment-based Drug Discovery Product Offered
11.3.3 Beactica Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Beactica Main Business Overview
11.3.5 Beactica Latest Developments
11.4 Charles River Laboratories
11.4.1 Charles River Laboratories Company Information
11.4.2 Charles River Laboratories Fragment-based Drug Discovery Product Offered
11.4.3 Charles River Laboratories Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Charles River Laboratories Main Business Overview
11.4.5 Charles River Laboratories Latest Developments
11.5 Crown Bioscience
11.5.1 Crown Bioscience Company Information
11.5.2 Crown Bioscience Fragment-based Drug Discovery Product Offered
11.5.3 Crown Bioscience Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Crown Bioscience Main Business Overview
11.5.5 Crown Bioscience Latest Developments
11.6 Emerald BioStructures
11.6.1 Emerald BioStructures Company Information
11.6.2 Emerald BioStructures Fragment-based Drug Discovery Product Offered
11.6.3 Emerald BioStructures Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Emerald BioStructures Main Business Overview
11.6.5 Emerald BioStructures Latest Developments
11.7 Evotec
11.7.1 Evotec Company Information
11.7.2 Evotec Fragment-based Drug Discovery Product Offered
11.7.3 Evotec Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Evotec Main Business Overview
11.7.5 Evotec Latest Developments
11.8 Kinetic Discovery
11.8.1 Kinetic Discovery Company Information
11.8.2 Kinetic Discovery Fragment-based Drug Discovery Product Offered
11.8.3 Kinetic Discovery Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Kinetic Discovery Main Business Overview
11.8.5 Kinetic Discovery Latest Developments
11.9 Proteros Fragments
11.9.1 Proteros Fragments Company Information
11.9.2 Proteros Fragments Fragment-based Drug Discovery Product Offered
11.9.3 Proteros Fragments Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Proteros Fragments Main Business Overview
11.9.5 Proteros Fragments Latest Developments
11.10 Sprint Bioscience
11.10.1 Sprint Bioscience Company Information
11.10.2 Sprint Bioscience Fragment-based Drug Discovery Product Offered
11.10.3 Sprint Bioscience Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Sprint Bioscience Main Business Overview
11.10.5 Sprint Bioscience Latest Developments
11.11 Structure Based Design
11.11.1 Structure Based Design Company Information
11.11.2 Structure Based Design Fragment-based Drug Discovery Product Offered
11.11.3 Structure Based Design Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Structure Based Design Main Business Overview
11.11.5 Structure Based Design Latest Developments
11.12 Sygnature Discovery
11.12.1 Sygnature Discovery Company Information
11.12.2 Sygnature Discovery Fragment-based Drug Discovery Product Offered
11.12.3 Sygnature Discovery Fragment-based Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Sygnature Discovery Main Business Overview
11.12.5 Sygnature Discovery Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Fragment-based Drug Discovery Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Fragment Screening
Table 3. Major Players of Fragment Optimization
Table 4. Fragment-based Drug Discovery Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Fragment-based Drug Discovery Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Fragment-based Drug Discovery Market Size Market Share by Type (2019-2024)
Table 7. Fragment-based Drug Discovery Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Fragment-based Drug Discovery Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Fragment-based Drug Discovery Market Size Market Share by Application (2019-2024)
Table 10. Global Fragment-based Drug Discovery Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Fragment-based Drug Discovery Revenue Market Share by Player (2019-2024)
Table 12. Fragment-based Drug Discovery Key Players Head office and Products Offered
Table 13. Fragment-based Drug Discovery Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Fragment-based Drug Discovery Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Fragment-based Drug Discovery Market Size Market Share by Regions (2019-2024)
Table 18. Global Fragment-based Drug Discovery Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Fragment-based Drug Discovery Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Fragment-based Drug Discovery Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Fragment-based Drug Discovery Market Size Market Share by Country (2019-2024)
Table 22. Americas Fragment-based Drug Discovery Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Fragment-based Drug Discovery Market Size Market Share by Type (2019-2024)
Table 24. Americas Fragment-based Drug Discovery Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Fragment-based Drug Discovery Market Size Market Share by Application (2019-2024)
Table 26. APAC Fragment-based Drug Discovery Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Fragment-based Drug Discovery Market Size Market Share by Region (2019-2024)
Table 28. APAC Fragment-based Drug Discovery Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Fragment-based Drug Discovery Market Size Market Share by Type (2019-2024)
Table 30. APAC Fragment-based Drug Discovery Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Fragment-based Drug Discovery Market Size Market Share by Application (2019-2024)
Table 32. Europe Fragment-based Drug Discovery Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Fragment-based Drug Discovery Market Size Market Share by Country (2019-2024)
Table 34. Europe Fragment-based Drug Discovery Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Fragment-based Drug Discovery Market Size Market Share by Type (2019-2024)
Table 36. Europe Fragment-based Drug Discovery Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Fragment-based Drug Discovery Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Fragment-based Drug Discovery Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Fragment-based Drug Discovery Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Fragment-based Drug Discovery Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Fragment-based Drug Discovery Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Fragment-based Drug Discovery Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Fragment-based Drug Discovery Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Fragment-based Drug Discovery
Table 45. Key Market Challenges & Risks of Fragment-based Drug Discovery
Table 46. Key Industry Trends of Fragment-based Drug Discovery
Table 47. Global Fragment-based Drug Discovery Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Fragment-based Drug Discovery Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Fragment-based Drug Discovery Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Fragment-based Drug Discovery Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Astex Pharmaceuticals Details, Company Type, Fragment-based Drug Discovery Area Served and Its Competitors
Table 52. Astex Pharmaceuticals Fragment-based Drug Discovery Product Offered
Table 53. Astex Pharmaceuticals Fragment-based Drug Discovery Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Astex Pharmaceuticals Main Business
Table 55. Astex Pharmaceuticals Latest Developments
Table 56. Alveus Pharmaceuticals Details, Company Type, Fragment-based Drug Discovery Area Served and Its Competitors
Table 57. Alveus Pharmaceuticals Fragment-based Drug Discovery Product Offered
Table 58. Alveus Pharmaceuticals Main Business
Table 59. Alveus Pharmaceuticals Fragment-based Drug Discovery Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Alveus Pharmaceuticals Latest Developments
Table 61. Beactica Details, Company Type, Fragment-based Drug Discovery Area Served and Its Competitors
Table 62. Beactica Fragment-based Drug Discovery Product Offered
Table 63. Beactica Main Business
Table 64. Beactica Fragment-based Drug Discovery Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Beactica Latest Developments
Table 66. Charles River Laboratories Details, Company Type, Fragment-based Drug Discovery Area Served and Its Competitors
Table 67. Charles River Laboratories Fragment-based Drug Discovery Product Offered
Table 68. Charles River Laboratories Main Business
Table 69. Charles River Laboratories Fragment-based Drug Discovery Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Charles River Laboratories Latest Developments
Table 71. Crown Bioscience Details, Company Type, Fragment-based Drug Discovery Area Served and Its Competitors
Table 72. Crown Bioscience Fragment-based Drug Discovery Product Offered
Table 73. Crown Bioscience Main Business
Table 74. Crown Bioscience Fragment-based Drug Discovery Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Crown Bioscience Latest Developments
Table 76. Emerald BioStructures Details, Company Type, Fragment-based Drug Discovery Area Served and Its Competitors
Table 77. Emerald BioStructures Fragment-based Drug Discovery Product Offered
Table 78. Emerald BioStructures Main Business
Table 79. Emerald BioStructures Fragment-based Drug Discovery Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Emerald BioStructures Latest Developments
Table 81. Evotec Details, Company Type, Fragment-based Drug Discovery Area Served and Its Competitors
Table 82. Evotec Fragment-based Drug Discovery Product Offered
Table 83. Evotec Main Business
Table 84. Evotec Fragment-based Drug Discovery Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Evotec Latest Developments
Table 86. Kinetic Discovery Details, Company Type, Fragment-based Drug Discovery Area Served and Its Competitors
Table 87. Kinetic Discovery Fragment-based Drug Discovery Product Offered
Table 88. Kinetic Discovery Main Business
Table 89. Kinetic Discovery Fragment-based Drug Discovery Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Kinetic Discovery Latest Developments
Table 91. Proteros Fragments Details, Company Type, Fragment-based Drug Discovery Area Served and Its Competitors
Table 92. Proteros Fragments Fragment-based Drug Discovery Product Offered
Table 93. Proteros Fragments Main Business
Table 94. Proteros Fragments Fragment-based Drug Discovery Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Proteros Fragments Latest Developments
Table 96. Sprint Bioscience Details, Company Type, Fragment-based Drug Discovery Area Served and Its Competitors
Table 97. Sprint Bioscience Fragment-based Drug Discovery Product Offered
Table 98. Sprint Bioscience Main Business
Table 99. Sprint Bioscience Fragment-based Drug Discovery Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Sprint Bioscience Latest Developments
Table 101. Structure Based Design Details, Company Type, Fragment-based Drug Discovery Area Served and Its Competitors
Table 102. Structure Based Design Fragment-based Drug Discovery Product Offered
Table 103. Structure Based Design Fragment-based Drug Discovery Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Structure Based Design Main Business
Table 105. Structure Based Design Latest Developments
Table 106. Sygnature Discovery Details, Company Type, Fragment-based Drug Discovery Area Served and Its Competitors
Table 107. Sygnature Discovery Fragment-based Drug Discovery Product Offered
Table 108. Sygnature Discovery Main Business
Table 109. Sygnature Discovery Fragment-based Drug Discovery Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. Sygnature Discovery Latest Developments
Table 1. Fragment-based Drug Discovery Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Fragment Screening
Table 3. Major Players of Fragment Optimization
Table 4. Fragment-based Drug Discovery Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Fragment-based Drug Discovery Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Fragment-based Drug Discovery Market Size Market Share by Type (2019-2024)
Table 7. Fragment-based Drug Discovery Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Fragment-based Drug Discovery Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Fragment-based Drug Discovery Market Size Market Share by Application (2019-2024)
Table 10. Global Fragment-based Drug Discovery Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Fragment-based Drug Discovery Revenue Market Share by Player (2019-2024)
Table 12. Fragment-based Drug Discovery Key Players Head office and Products Offered
Table 13. Fragment-based Drug Discovery Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Fragment-based Drug Discovery Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Fragment-based Drug Discovery Market Size Market Share by Regions (2019-2024)
Table 18. Global Fragment-based Drug Discovery Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Fragment-based Drug Discovery Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Fragment-based Drug Discovery Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Fragment-based Drug Discovery Market Size Market Share by Country (2019-2024)
Table 22. Americas Fragment-based Drug Discovery Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Fragment-based Drug Discovery Market Size Market Share by Type (2019-2024)
Table 24. Americas Fragment-based Drug Discovery Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Fragment-based Drug Discovery Market Size Market Share by Application (2019-2024)
Table 26. APAC Fragment-based Drug Discovery Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Fragment-based Drug Discovery Market Size Market Share by Region (2019-2024)
Table 28. APAC Fragment-based Drug Discovery Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Fragment-based Drug Discovery Market Size Market Share by Type (2019-2024)
Table 30. APAC Fragment-based Drug Discovery Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Fragment-based Drug Discovery Market Size Market Share by Application (2019-2024)
Table 32. Europe Fragment-based Drug Discovery Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Fragment-based Drug Discovery Market Size Market Share by Country (2019-2024)
Table 34. Europe Fragment-based Drug Discovery Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Fragment-based Drug Discovery Market Size Market Share by Type (2019-2024)
Table 36. Europe Fragment-based Drug Discovery Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Fragment-based Drug Discovery Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Fragment-based Drug Discovery Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Fragment-based Drug Discovery Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Fragment-based Drug Discovery Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Fragment-based Drug Discovery Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Fragment-based Drug Discovery Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Fragment-based Drug Discovery Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Fragment-based Drug Discovery
Table 45. Key Market Challenges & Risks of Fragment-based Drug Discovery
Table 46. Key Industry Trends of Fragment-based Drug Discovery
Table 47. Global Fragment-based Drug Discovery Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Fragment-based Drug Discovery Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Fragment-based Drug Discovery Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Fragment-based Drug Discovery Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Astex Pharmaceuticals Details, Company Type, Fragment-based Drug Discovery Area Served and Its Competitors
Table 52. Astex Pharmaceuticals Fragment-based Drug Discovery Product Offered
Table 53. Astex Pharmaceuticals Fragment-based Drug Discovery Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Astex Pharmaceuticals Main Business
Table 55. Astex Pharmaceuticals Latest Developments
Table 56. Alveus Pharmaceuticals Details, Company Type, Fragment-based Drug Discovery Area Served and Its Competitors
Table 57. Alveus Pharmaceuticals Fragment-based Drug Discovery Product Offered
Table 58. Alveus Pharmaceuticals Main Business
Table 59. Alveus Pharmaceuticals Fragment-based Drug Discovery Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Alveus Pharmaceuticals Latest Developments
Table 61. Beactica Details, Company Type, Fragment-based Drug Discovery Area Served and Its Competitors
Table 62. Beactica Fragment-based Drug Discovery Product Offered
Table 63. Beactica Main Business
Table 64. Beactica Fragment-based Drug Discovery Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Beactica Latest Developments
Table 66. Charles River Laboratories Details, Company Type, Fragment-based Drug Discovery Area Served and Its Competitors
Table 67. Charles River Laboratories Fragment-based Drug Discovery Product Offered
Table 68. Charles River Laboratories Main Business
Table 69. Charles River Laboratories Fragment-based Drug Discovery Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Charles River Laboratories Latest Developments
Table 71. Crown Bioscience Details, Company Type, Fragment-based Drug Discovery Area Served and Its Competitors
Table 72. Crown Bioscience Fragment-based Drug Discovery Product Offered
Table 73. Crown Bioscience Main Business
Table 74. Crown Bioscience Fragment-based Drug Discovery Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Crown Bioscience Latest Developments
Table 76. Emerald BioStructures Details, Company Type, Fragment-based Drug Discovery Area Served and Its Competitors
Table 77. Emerald BioStructures Fragment-based Drug Discovery Product Offered
Table 78. Emerald BioStructures Main Business
Table 79. Emerald BioStructures Fragment-based Drug Discovery Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Emerald BioStructures Latest Developments
Table 81. Evotec Details, Company Type, Fragment-based Drug Discovery Area Served and Its Competitors
Table 82. Evotec Fragment-based Drug Discovery Product Offered
Table 83. Evotec Main Business
Table 84. Evotec Fragment-based Drug Discovery Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Evotec Latest Developments
Table 86. Kinetic Discovery Details, Company Type, Fragment-based Drug Discovery Area Served and Its Competitors
Table 87. Kinetic Discovery Fragment-based Drug Discovery Product Offered
Table 88. Kinetic Discovery Main Business
Table 89. Kinetic Discovery Fragment-based Drug Discovery Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Kinetic Discovery Latest Developments
Table 91. Proteros Fragments Details, Company Type, Fragment-based Drug Discovery Area Served and Its Competitors
Table 92. Proteros Fragments Fragment-based Drug Discovery Product Offered
Table 93. Proteros Fragments Main Business
Table 94. Proteros Fragments Fragment-based Drug Discovery Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Proteros Fragments Latest Developments
Table 96. Sprint Bioscience Details, Company Type, Fragment-based Drug Discovery Area Served and Its Competitors
Table 97. Sprint Bioscience Fragment-based Drug Discovery Product Offered
Table 98. Sprint Bioscience Main Business
Table 99. Sprint Bioscience Fragment-based Drug Discovery Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Sprint Bioscience Latest Developments
Table 101. Structure Based Design Details, Company Type, Fragment-based Drug Discovery Area Served and Its Competitors
Table 102. Structure Based Design Fragment-based Drug Discovery Product Offered
Table 103. Structure Based Design Fragment-based Drug Discovery Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Structure Based Design Main Business
Table 105. Structure Based Design Latest Developments
Table 106. Sygnature Discovery Details, Company Type, Fragment-based Drug Discovery Area Served and Its Competitors
Table 107. Sygnature Discovery Fragment-based Drug Discovery Product Offered
Table 108. Sygnature Discovery Main Business
Table 109. Sygnature Discovery Fragment-based Drug Discovery Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. Sygnature Discovery Latest Developments
LIST OF FIGURES
Figure 1. Fragment-based Drug Discovery Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Fragment-based Drug Discovery Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Fragment-based Drug Discovery Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Fragment-based Drug Discovery Sales Market Share by Country/Region (2023)
Figure 8. Fragment-based Drug Discovery Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Fragment-based Drug Discovery Market Size Market Share by Type in 2023
Figure 10. Fragment-based Drug Discovery in Academic and Research Institutions
Figure 11. Global Fragment-based Drug Discovery Market: Academic and Research Institutions (2019-2024) & ($ Millions)
Figure 12. Fragment-based Drug Discovery in Biopharmaceutical Companies
Figure 13. Global Fragment-based Drug Discovery Market: Biopharmaceutical Companies (2019-2024) & ($ Millions)
Figure 14. Fragment-based Drug Discovery in Contract Research Organizations (CROs)
Figure 15. Global Fragment-based Drug Discovery Market: Contract Research Organizations (CROs) (2019-2024) & ($ Millions)
Figure 16. Global Fragment-based Drug Discovery Market Size Market Share by Application in 2023
Figure 17. Global Fragment-based Drug Discovery Revenue Market Share by Player in 2023
Figure 18. Global Fragment-based Drug Discovery Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Fragment-based Drug Discovery Market Size 2019-2024 ($ Millions)
Figure 20. APAC Fragment-based Drug Discovery Market Size 2019-2024 ($ Millions)
Figure 21. Europe Fragment-based Drug Discovery Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Fragment-based Drug Discovery Market Size 2019-2024 ($ Millions)
Figure 23. Americas Fragment-based Drug Discovery Value Market Share by Country in 2023
Figure 24. United States Fragment-based Drug Discovery Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Fragment-based Drug Discovery Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Fragment-based Drug Discovery Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Fragment-based Drug Discovery Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Fragment-based Drug Discovery Market Size Market Share by Region in 2023
Figure 29. APAC Fragment-based Drug Discovery Market Size Market Share by Type in 2023
Figure 30. APAC Fragment-based Drug Discovery Market Size Market Share by Application in 2023
Figure 31. China Fragment-based Drug Discovery Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Fragment-based Drug Discovery Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Fragment-based Drug Discovery Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Fragment-based Drug Discovery Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Fragment-based Drug Discovery Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Fragment-based Drug Discovery Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Fragment-based Drug Discovery Market Size Market Share by Country in 2023
Figure 38. Europe Fragment-based Drug Discovery Market Size Market Share by Type (2019-2024)
Figure 39. Europe Fragment-based Drug Discovery Market Size Market Share by Application (2019-2024)
Figure 40. Germany Fragment-based Drug Discovery Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Fragment-based Drug Discovery Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Fragment-based Drug Discovery Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Fragment-based Drug Discovery Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Fragment-based Drug Discovery Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Fragment-based Drug Discovery Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Fragment-based Drug Discovery Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Fragment-based Drug Discovery Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Fragment-based Drug Discovery Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Fragment-based Drug Discovery Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Fragment-based Drug Discovery Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Fragment-based Drug Discovery Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Fragment-based Drug Discovery Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 54. APAC Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 55. Europe Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 57. United States Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 58. Canada Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 61. China Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 62. Japan Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 63. Korea Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 65. India Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 66. Australia Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 67. Germany Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 68. France Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 69. UK Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 70. Italy Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 71. Russia Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 72. Spain Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 75. Israel Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 78. Global Fragment-based Drug Discovery Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Fragment-based Drug Discovery Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Fragment-based Drug Discovery Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Fragment-based Drug Discovery Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Fragment-based Drug Discovery Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Fragment-based Drug Discovery Sales Market Share by Country/Region (2023)
Figure 8. Fragment-based Drug Discovery Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Fragment-based Drug Discovery Market Size Market Share by Type in 2023
Figure 10. Fragment-based Drug Discovery in Academic and Research Institutions
Figure 11. Global Fragment-based Drug Discovery Market: Academic and Research Institutions (2019-2024) & ($ Millions)
Figure 12. Fragment-based Drug Discovery in Biopharmaceutical Companies
Figure 13. Global Fragment-based Drug Discovery Market: Biopharmaceutical Companies (2019-2024) & ($ Millions)
Figure 14. Fragment-based Drug Discovery in Contract Research Organizations (CROs)
Figure 15. Global Fragment-based Drug Discovery Market: Contract Research Organizations (CROs) (2019-2024) & ($ Millions)
Figure 16. Global Fragment-based Drug Discovery Market Size Market Share by Application in 2023
Figure 17. Global Fragment-based Drug Discovery Revenue Market Share by Player in 2023
Figure 18. Global Fragment-based Drug Discovery Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Fragment-based Drug Discovery Market Size 2019-2024 ($ Millions)
Figure 20. APAC Fragment-based Drug Discovery Market Size 2019-2024 ($ Millions)
Figure 21. Europe Fragment-based Drug Discovery Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Fragment-based Drug Discovery Market Size 2019-2024 ($ Millions)
Figure 23. Americas Fragment-based Drug Discovery Value Market Share by Country in 2023
Figure 24. United States Fragment-based Drug Discovery Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Fragment-based Drug Discovery Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Fragment-based Drug Discovery Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Fragment-based Drug Discovery Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Fragment-based Drug Discovery Market Size Market Share by Region in 2023
Figure 29. APAC Fragment-based Drug Discovery Market Size Market Share by Type in 2023
Figure 30. APAC Fragment-based Drug Discovery Market Size Market Share by Application in 2023
Figure 31. China Fragment-based Drug Discovery Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Fragment-based Drug Discovery Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Fragment-based Drug Discovery Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Fragment-based Drug Discovery Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Fragment-based Drug Discovery Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Fragment-based Drug Discovery Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Fragment-based Drug Discovery Market Size Market Share by Country in 2023
Figure 38. Europe Fragment-based Drug Discovery Market Size Market Share by Type (2019-2024)
Figure 39. Europe Fragment-based Drug Discovery Market Size Market Share by Application (2019-2024)
Figure 40. Germany Fragment-based Drug Discovery Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Fragment-based Drug Discovery Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Fragment-based Drug Discovery Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Fragment-based Drug Discovery Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Fragment-based Drug Discovery Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Fragment-based Drug Discovery Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Fragment-based Drug Discovery Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Fragment-based Drug Discovery Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Fragment-based Drug Discovery Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Fragment-based Drug Discovery Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Fragment-based Drug Discovery Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Fragment-based Drug Discovery Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Fragment-based Drug Discovery Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 54. APAC Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 55. Europe Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 57. United States Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 58. Canada Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 61. China Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 62. Japan Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 63. Korea Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 65. India Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 66. Australia Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 67. Germany Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 68. France Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 69. UK Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 70. Italy Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 71. Russia Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 72. Spain Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 75. Israel Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Fragment-based Drug Discovery Market Size 2025-2030 ($ Millions)
Figure 78. Global Fragment-based Drug Discovery Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Fragment-based Drug Discovery Market Size Market Share Forecast by Application (2025-2030)
